BridgeBio Pharma, Inc 10-K for FY2019
BridgeBio Pharma, Inc. (BBIO)
10-K
2020-03-03
For: 2019-12-31
View Original
Added on
April 08, 2026
About this 10-K
BridgeBio Pharma, Inc filed this 10-K on March 3, 2020, covering the fiscal year ended December 31, 2019 (FY2019).
Headline figures
Fiscal year ended December 31, 2019, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $40.56M
- Net loss
- $288.59M
- compared with a net loss of $169.45M a year earlier